Amgen v. Sanofi Sup Ct. oral arguments took place yesterday in the ongoing PCSK9* antibody (Ab) patent case. See the attached transcript and FIG. 1. Who won the oral arguments? Verdict? Although it's hard to predict the outcome of the case from the oral arguments, I give the advantage in the orals to Sanofi Some of the Sup Ct justices don't like that AMGN's patent covers millions of antibodies (Abs) and only discloses 26 Abs And the fact that there is no structure, only funct

Updated 9/6/22 Summary The Euorpean Society for Medical Oncology (ESMO) takes place from Sept 9-13, 2022 in Paris ESMO is "the most...

SUMMARY Biotech stocks were up ~14% last week The huge biotech stock week was driven mainly by biotech M&A activity It's unlikely that...

(Originally posted 7/25/2022, updated 7/27/22) Summary BPIQ monitors mergers and acquisitions (M&A's) of smid-cap biopharmas Acquisition...